Observational studyBMC geriatrics2026
Safe homecoming intervention after hospital discharge: a retrospective cohort study of mortality and readmission among patients 75 years or older in Sweden.
Observational study in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAfter a hospital stay, older patients are at increased risk of health complications that may lead to readmission to hospital or premature death. Globally, numerous interventions have been applied to enhance transitional care for older patients, but the evidence base remains inconclusive. One form of a transitional care intervention is the Swedish primary health care Safe homecoming intervention, a time-limited, interprofessional and tailored home health care intervention designed to prevent avoidable complications and readmissions following hospital discharge. The effects of Safe homecoming have not yet been scientifically evaluated. The present study aimed to assess the association between the interprofessional Safe homecoming intervention and the risk of death or readmission.
methodsWe conducted a retrospective propensity score-matched cohort study in Örebro County, Sweden, using administrative and medical-record data from 2013 to 2020. The source cohort comprised 38,338 patients aged 75 years or older who had been admitted to hospital for at least one day. We included 128 patients who received the interprofessional Safe homecoming intervention at a single primary health care centre between 1 November 2016 and 31 May 2019 and 512 propensity score-matched controls from across the county receiving standard care.
resultsThe mean age was 85.5 years, and 60.9% of patients in both groups were women. At 90 days, the cumulative incidence of first hospital readmission was 20.3% in the intervention group and 33.6% among controls (Gray's test p = 0.005). In the competing-risk analysis, the Fine-Gray subdistribution hazard ratio was 0.57 (95% CI 0.37-0.86; p = 0.008). The corresponding cause-specific Cox model yielded an HR of 0.55 (95% CI 0.36-0.84; p = 0.005). At 365 days, the Fine-Gray estimate was 0.79 (95% CI 0.59-1.05; p = 0.098). Mortality estimates favoured the intervention group numerically but were imprecise, with confidence intervals including the null at all evaluated follow-up times.
conclusionThe Safe Homecoming intervention was associated with a lower risk of first hospital readmission at 90 days, whereas there was no clear evidence of an association with mortality or longer-term readmission. Given the observational design, small intervention sample, potential residual confounding and evaluation of multiple follow-up time points, these findings should be considered exploratory and require confirmation in larger prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.